AGL 38.00 Increased By ▲ 0.50 (1.33%)
AIRLINK 218.49 Decreased By ▼ -4.40 (-1.97%)
BOP 10.80 Decreased By ▼ -0.02 (-0.18%)
CNERGY 7.46 Decreased By ▼ -0.10 (-1.32%)
DCL 9.15 Decreased By ▼ -0.27 (-2.87%)
DFML 40.70 Decreased By ▼ -0.26 (-0.63%)
DGKC 102.75 Decreased By ▼ -4.01 (-3.76%)
FCCL 34.95 Decreased By ▼ -2.12 (-5.72%)
FFL 19.60 Increased By ▲ 0.36 (1.87%)
HASCOL 12.95 Decreased By ▼ -0.23 (-1.75%)
HUBC 131.26 Decreased By ▼ -1.38 (-1.04%)
HUMNL 14.50 Decreased By ▼ -0.23 (-1.56%)
KEL 5.33 Decreased By ▼ -0.07 (-1.3%)
KOSM 7.48 No Change ▼ 0.00 (0%)
MLCF 45.85 Decreased By ▼ -2.33 (-4.84%)
NBP 65.85 Decreased By ▼ -0.44 (-0.66%)
OGDC 221.20 Decreased By ▼ -2.06 (-0.92%)
PAEL 44.36 Increased By ▲ 0.86 (1.98%)
PIBTL 9.14 Increased By ▲ 0.07 (0.77%)
PPL 193.25 Decreased By ▼ -4.99 (-2.52%)
PRL 41.75 Decreased By ▼ -0.49 (-1.16%)
PTC 26.85 Decreased By ▼ -0.54 (-1.97%)
SEARL 108.00 Decreased By ▼ -2.08 (-1.89%)
TELE 10.45 Decreased By ▼ -0.07 (-0.67%)
TOMCL 35.89 Decreased By ▼ -0.73 (-1.99%)
TPLP 14.60 Decreased By ▼ -0.35 (-2.34%)
TREET 26.35 Decreased By ▼ -0.18 (-0.68%)
TRG 67.45 Decreased By ▼ -1.40 (-2.03%)
UNITY 33.50 Decreased By ▼ -0.69 (-2.02%)
WTL 1.77 Decreased By ▼ -0.02 (-1.12%)
BR100 12,370 Increased By 6.3 (0.05%)
BR30 37,423 Decreased By -795.5 (-2.08%)
KSE100 116,637 Decreased By -482.9 (-0.41%)
KSE30 36,770 Decreased By -166.8 (-0.45%)

An investigator has backed the World Anti-Doping Agency’s handling of a case involving 23 Chinese swimmers who failed drug tests weeks before the Tokyo Games and said WADA had not been complacent nor shown bias towards China.

Swiss prosecutor Eric Cottier, who was handpicked by the global anti-doping agency, said in July WADA did not mishandle the case involving the swimmers, who tested positive for trimetazidine (TMZ) but were cleared by a Chinese investigation.

Cottier reiterated those findings in his final report on Thursday but also criticized WADA for failing to challenge Chinese anti-doping authorities (CHINADA) for not following all of the procedures laid down in its anti-doping standard.

“Nothing in the file - which is complete - suggests that WADA showed favoritism or complacency, or in any way benefited the 23 swimmers who tested positive for TMZ,” Cottier said in the conclusion of his 59-page report. He also found WADA’s decision not to appeal CHINADA’s decision not to bring forward anti-doping rule violations against the swimmers “reasonable”.

CHINADA had said the swimmers were inadvertently exposed to TMZ – a medication that increases blood flow to the heart – through contamination. It said traces of the drug were found in the kitchen of the hotel they were staying, and the case was not made public.

WADA to hold extraordinary meeting in Chinese swimmers case

WADA’s science department then determined that scenario was plausible.

The case prompted a backlash from athletes and national anti-doping authorities, who questioned WADA’s processes and complained about a lack of transparency in the case.

WADA Director General Olivier Niggli said in a statement on Thursday that Cottier’s report had “unambiguously stressed that WADA’s review was thorough, professional and followed the rules”.

“Above all, (Cottier) reiterated that WADA showed no bias towards China and that its decision not to appeal the cases was reasonable based on the evidence.”

Travis Tygart, the CEO of the US Anti-Doping Authority (USADA) and an outspoken critic of WADA’s handling of the case, was not satisfied with the report’s conclusions.

“While WADA management wants to close the book on this scandal regarding 23 positive TMZ cases by Chinese swimmers, the full report released today by WADA’s investigator only validates our concerns and even raises new questions that must be answered,” he said.

“The ongoing failure to investigate and to answer the critical question of whether the 23 positive tests were due to contamination or intentional use will haunt athletes around the world for years to come.”

Comments

200 characters